|
Market Closed -
Other stock markets
|
After market 03:56:40 pm | |||
| 53.80 EUR | -0.55% |
|
53.76 | -0.07% |
| 10:30am | SIEMENS HEALTHINEERS : Bernstein remains its Buy rating | ZD |
| Dec. 11 | SIEMENS HEALTHINEERS : Jefferies gives a Buy rating | ZD |
| Capitalization | 60.55B 63.49B 56.15B 49.81B 89.78B 5,383B 99.73B 697B 258B 2,214B 239B 233B 9,682B | P/E ratio 2025 * |
25.6x | P/E ratio 2026 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise value | 72.53B 76.05B 67.25B 59.66B 108B 6,448B 119B 835B 309B 2,652B 286B 279B 11,597B | EV / Sales 2025 * |
3.07x | EV / Sales 2026 * | 2.84x |
| Free-Float |
23.56% | Yield 2025 * |
2.03% | Yield 2026 * | 2.32% |
More valuation ratios
* Estimated data
More news
Last Transcript: Siemens Healthineers AG
More recommendations
More press releases
More news
| 1 day | -0.55% | ||
| 1 week | +4.02% | ||
| Current month | +4.83% | ||
| 1 month | +6.58% | ||
| 3 months | +7.60% | ||
| 6 months | -2.07% | ||
| Current year | +2.28% |
1 week
50.42
54.18
1 month
48.7954.18
Current year
47.3158.14
1 year
47.3158.14
3 years
40.3267.44
5 years
28.5067.66
10 years
28.5067.66
| Director | Title | Age | Since |
|---|---|---|---|
Bernhard Montag
CEO | Chief Executive Officer | 55 | 2015-01-31 |
Jochen Schmitz
DFI | Director of Finance/CFO | 58 | 2017-11-30 |
Peter Schardt
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2018-02-28 | |
| Chairman | 63 | 2019-11-30 | |
Marion Helmes
BRD | Director/Board Member | 59 | 2018-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.90% | 18 M€ | +7.68% | ||
| 1.48% | 2 M€ | +13.56% | - | |
| 1.11% | 962 M€ | -.--% | - | |
| 1.11% | 0 M€ | +62.64% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.55% | +4.02% | +2.44% | -19.07% | 63.49B | ||
| -1.41% | +1.54% | +6.33% | -18.13% | 204B | ||
| +0.82% | +0.10% | +70.93% | +61.06% | 194B | ||
| +0.07% | +3.52% | +7.34% | -25.94% | 170B | ||
| +0.26% | +0.44% | +62.52% | +119.48% | 133B | ||
| +2.66% | +3.74% | -9.59% | -27.34% | 43.69B | ||
| +0.34% | +2.82% | +3.18% | -38.32% | 43.53B | ||
| -0.22% | +2.43% | +9.65% | -9.64% | 40.27B | ||
| -1.10% | +0.61% | +13.89% | - | 37.81B | ||
| +0.39% | +3.19% | +47.29% | -6.24% | 36.07B | ||
| Average | +0.10% | +0.30% | +21.40% | +3.98% | 96.64B | |
| Weighted average by Cap. | -0.03% | -0.15% | +28.06% | +16.12% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 23.61B 24.75B 21.89B 19.42B 35B 2,099B 38.88B 272B 101B 863B 92.98B 90.92B 3,774B | 25.06B 26.28B 23.24B 20.62B 37.16B 2,228B 41.28B 289B 107B 916B 98.73B 96.54B 4,007B |
| Net income | 2.37B 2.49B 2.2B 1.95B 3.52B 211B 3.91B 27.35B 10.13B 86.8B 9.35B 9.15B 380B | 2.76B 2.9B 2.56B 2.27B 4.1B 246B 4.55B 31.84B 11.79B 101B 10.89B 10.65B 442B |
| Net Debt | 11.98B 12.56B 11.11B 9.85B 17.76B 1,065B 19.73B 138B 51.09B 438B 47.18B 46.13B 1,915B | 10.65B 11.17B 9.88B 8.76B 15.79B 947B 17.54B 123B 45.43B 389B 41.95B 41.02B 1,703B |
More financial data
* Estimated data
Employees
72,000
Calendar
2025-02-05
- Q1 2025 Earnings Call
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-12 | 53.80 € | -0.55% | 774,834 |
| 24-12-11 | 54.10 € | +1.08% | 729,464 |
| 24-12-10 | 53.52 € | +2.22% | 820,276 |
| 24-12-09 | 52.36 € | +1.79% | 434,375 |
| 24-12-06 | 51.44 € | -0.54% | 595,025 |
Delayed Quote Xetra, December 12, 2024 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
54.10EUR
Average target price
59.56EUR
Spread / Average Target
+10.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SHL Stock